Deloitte Launches CognitiveSpark™ for Marketing Artificial Intelligence Solution
Deloitte announced the launch of its ConvergeHEALTH CognitiveSpark™ for Marketing artificial intelligence (AI) precision engagement solution, a module of the CognitiveSpark suite...
NEW YORK, Oct. 5, 2021 — Deloitte today announced the launch of its ConvergeHEALTH CognitiveSpark™ for Marketing artificial intelligence (AI) precision engagement solution a module of the CognitiveSpark suite.
AI in pharma and life sciences
See how AI is reshaping pharmaceutical’s value chain in the Age of With™
From molecule to market, there are significant benefits to applying artificial intelligence at every stage of the life sciences value chain. Welcome to pharma in The Age of With™.
Cell and gene therapy
Opportunities and challenges to personalized medicine
Advancements in next-generation cell and gene therapies are fulfilling the promise of personalized medicine and attempting to cure and heal patients rather than ameliorating symptoms. Multiple approved products have been launched in global markets and the number of clinical trials continues to grow.
Bringing new therapies to patients
Transforming clinical development
Transformative approaches to drug development have the potential to improve the efficiency of R&D, bring new therapies to market earlier, and improve the patient experience during clinical trials. What can biopharma companies do to expand their application?